Signaturefd LLC lowered its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 3.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,792 shares of the semiconductor company’s stock after selling 144 shares during the period. Signaturefd LLC’s holdings in Synopsys were worth $1,920,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. ORG Partners LLC increased its stake in Synopsys by 600.0% in the 2nd quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 36 shares during the period. Pacifica Partners Inc. bought a new position in shares of Synopsys in the third quarter worth approximately $25,000. Tsfg LLC increased its stake in shares of Synopsys by 75.0% in the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after buying an additional 24 shares during the period. Chris Bulman Inc bought a new stake in Synopsys during the 2nd quarter valued at $30,000. Finally, Fortitude Family Office LLC boosted its position in Synopsys by 66.7% during the 2nd quarter. Fortitude Family Office LLC now owns 60 shares of the semiconductor company’s stock valued at $36,000 after buying an additional 24 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of Synopsys stock opened at $502.41 on Wednesday. Synopsys, Inc. has a 1 year low of $448.91 and a 1 year high of $629.38. The firm has a market cap of $77.18 billion, a price-to-earnings ratio of 52.12, a PEG ratio of 3.47 and a beta of 1.08. The company has a 50-day moving average of $511.19 and a 200 day moving average of $546.60.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on SNPS shares. JPMorgan Chase & Co. boosted their price objective on shares of Synopsys from $655.00 to $685.00 and gave the company an “overweight” rating in a research report on Thursday, August 22nd. Piper Sandler restated an “overweight” rating and set a $687.00 price target on shares of Synopsys in a report on Thursday, August 22nd. Rosenblatt Securities reaffirmed a “buy” rating and set a $635.00 price target on shares of Synopsys in a research report on Friday, August 23rd. Robert W. Baird lifted their price objective on Synopsys from $661.00 to $663.00 and gave the stock an “outperform” rating in a research report on Thursday, August 22nd. Finally, Mizuho began coverage on Synopsys in a report on Tuesday. They set an “outperform” rating and a $650.00 target price for the company. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $644.55.
Read Our Latest Research Report on SNPS
Insider Transactions at Synopsys
In other news, CEO Sassine Ghazi sold 10,293 shares of Synopsys stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $553.89, for a total value of $5,701,189.77. Following the completion of the transaction, the chief executive officer now owns 62,568 shares of the company’s stock, valued at $34,655,789.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.66% of the company’s stock.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- 3 Monster Growth Stocks to Buy Now
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Options Trading – Understanding Strike Price
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.